4//SEC Filing
Senner Christopher J. 4
Accession 0000939767-25-000033
CIK 0000939767other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 8:00 PM ET
Size
10.0 KB
Accession
0000939767-25-000033
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Senner Christopher J.
EVP and CFO
Transactions
- Exercise/Conversion
Common Stock
2025-02-24$18.80/sh+29,314$551,103→ 808,921 total - Sale
Common Stock
2025-02-24$36.14/sh−29,314$1,059,408→ 779,607 total - Exercise/Conversion
Option (right to buy)
2025-02-24−29,314→ 100,000 totalExercise: $18.80From: 2019-09-10Exp: 2025-09-09→ Common Stock (29,314 underlying)
Holdings
- 2,723(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Includes 266,700 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.11 to $36.21. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- [F3]Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 24, 2025.
- [F4]The option, representing the right to purchase a total of 129,314 shares of Common Stock, became fully exercisable on September 10, 2022.
Documents
Issuer
EXELIXIS, INC.
CIK 0000939767
Entity typeother
Related Parties
1- filerCIK 0001648367
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 8:00 PM ET
- Size
- 10.0 KB